Indiana University is home to comprehensive interdisciplinary work in the field of rare metabolic diseases research. Dr. Michael Econs', our division chief, and Dr. Erik Imel's extensive work in this field has culminated in the FDA approval of a new drug for X-linked hypophosphatemia. For more information about conducting research studies with our metabolic research team please contact our Clinical Research Leader at firstname.lastname@example.org. To stay up to date on studies or our team please check out our Facebook page. Check out the Indiana Center for Musculoskeletal Health for more details about the comprehensive work being done at IU.